Andrew Witty: European price cuts have been restrained
This article was originally published in Scrip
Executive Summary
Price cuts announced recently in Europe in response to the economic crisis "have been restrained", said Andrew Witty, CEO of GlaxoSmithKline and president of the European Federation of Pharmaceutical Industry Associations (EFPIA), at a London press conference yesterday.